Lupus patients get custom steroid tapering plan in new study
NCT ID NCT03187743
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a personalized way to reduce steroid doses in 72 lupus patients. Doctors used blood tests and regular check-ups over 3 months to safely lower prednisone. The goal was to find the best tapering schedule for each person, minimizing side effects while controlling the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Necker Enfants Malades
Paris, Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new antibody help lupus patients ditch steroids?
- Ear zap may calm lupus pain by taming inflammation
- Engineered immune cells take aim at Hard-to-Treat lupus
- Are women with autoimmune diseases getting the gynecological care they need?
- Can a lupus drug help when given early?
- New drug cevostamab enters early human testing for lupus